![Karine Lignel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karine Lignel
Founder at
ONCODESIGN PRECISION MEDICINE
Profile
Karine Lignel is the founder of Oncodesign Precision Medicine SA, founded in 2020, holding the title of Chief Operating Officer, Director & Deputy MD.
Current jobs include Chairman at Société Financière Aquitaine De Participation, Director, Group Chief Development Officer & SVP at Oncodesign SA since 2021, and Director at SILIOS Technologies SA. Former jobs include Director at Ariana Pharmaceuticals SA, Amorçage Rhône-Alpes SAS as Investment Director, Sartorius Polyplus SAS as Director, Confederation Nationale Crédit Mutuel SA as Director, EndoControl SAS as Director, Voluntis SA as Non-Voting Director, ImmunID SAS as Director, e(ye).
Brain SA as Director, Global Bioenergies SA as Director from 2013 to 2020, Tissium SA as Director, Maat Pharma SA as Director, CM-CIC Innovation SASU as Investment Director from 2013 to 2016, Krono-Safe SA as Director, Coldway SA as Member-Supervisory Board, Rhones Alpes Creation as Member-Supervisory Board, Nanobiotix SA as Member-Supervisory Board, MedinCell SA as Member-Supervisory Board, and ForCity SAS as Member-Supervisory Board.
Education includes an MBA from ESSEC Business School and undergraduate studies at Ecole Superieure des Industries Agricoles et Alimentaires.
Karine Lignel active positions
| Companies | Position | Start |
|---|---|---|
| ONCODESIGN | Director/Board Member | 14/05/2008 |
| ONCODESIGN PRECISION MEDICINE | Founder | 15/12/2020 |
Société Financière Aquitaine De Participation
 Société Financière Aquitaine De Participation Financial ConglomeratesFinance Functions as an investment holding company | Chairman | - |
SILIOS Technologies SA
 SILIOS Technologies SA Electronic ComponentsElectronic Technology Manufactures optical miniature parts | Director/Board Member | - |
Former positions of Karine Lignel
| Companies | Position | End |
|---|---|---|
| GLOBAL BIOENERGIES SA | Director/Board Member | 01/03/2020 |
CM-CIC Innovation SASU
 CM-CIC Innovation SASU Investment ManagersFinance CM-CIC Innovation invests in companies located in France. The firm targets companies operating in deeptech, software & IT and health sectors. It provides financing for early stage transactions, It acts as a lead investor. | Private Equity Investor | 01/03/2016 |
Ariana Pharmaceuticals SA
 Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Provides pharmaceutical, clinical and data technology | Director/Board Member | - |
| NANOBIOTIX | Director/Board Member | - |
| VOLUNTIS S.A. | Director/Board Member | - |
Training of Karine Lignel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
35
1st degree connections
24
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 24 |
|---|---|
Ariana Pharmaceuticals SA
Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Provides pharmaceutical, clinical and data technology | Health Technology |
ESSEC Business School
 ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CM-CIC Innovation SASU
CM-CIC Innovation SASU Investment ManagersFinance CM-CIC Innovation invests in companies located in France. The firm targets companies operating in deeptech, software & IT and health sectors. It provides financing for early stage transactions, It acts as a lead investor. | Finance |
Amorçage Rhône-Alpes SAS
 Amorçage Rhône-Alpes SAS Investment ManagersFinance ARA is an active manager which invests in innovative French technology companies with high growth potential in a range of sectors including biotechnology, information technology and telecom, medical technology, nanotechnology and environment. The firm seeks to invest EUR 50,000-200,000 in companies which are either in their creation stage or have been in operation for less than two years, which are based in the administrative territory of the Rhone-Alpes region and which have technology originating from, or being developed in cooperation with a French public research institution. ARA usually co-invests with other financing partners and typically expects to exit their investments after three to seven years. The firm's investment committee makes the investment decisions. | Finance |
Coldway SA
 Coldway SA Wholesale DistributorsDistribution Services Manufactures refrigerated and insulated containers | Distribution Services |
Oncodesign SA
 Oncodesign SA BiotechnologyHealth Technology Develops preclinical evaluation of novel anticancer therapies | Health Technology |
Polyplus-transfection SA
 Polyplus-transfection SA BiotechnologyHealth Technology Provides cell and gene therapy services | Health Technology |
Confederation Nationale Crédit Mutuel SA
 Confederation Nationale Crédit Mutuel SA Major BanksFinance Provides national banking services | Finance |
Rhones Alpes Creation | |
EndoControl SAS
 EndoControl SAS Medical SpecialtiesHealth Technology Designs, develops and markets robotics solutions for laparoscopic surgeries | Health Technology |
Nanobiotix SA
 Nanobiotix SA Pharmaceuticals: MajorHealth Technology Develops and manufactures nanotherapeutics for treatment of cancer | Health Technology |
Ecole Superieure des Industries Agricoles et Alimentaires
 Ecole Superieure des Industries Agricoles et Alimentaires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voluntis SA
 Voluntis SA Packaged SoftwareTechnology Services Develops anti-cancer treatment platform | Technology Services |
SILIOS Technologies SA
SILIOS Technologies SA Electronic ComponentsElectronic Technology Manufactures optical miniature parts | Electronic Technology |
ImmunID SAS
 ImmunID SAS Medical SpecialtiesHealth Technology Researches and develops diagnostic tools for monitoring immune cell repertoire | Health Technology |
e(ye) Brain SA
 e(ye) Brain SA Medical DistributorsDistribution Services Provides medical research services | Distribution Services |
Global Bioenergies SA
 Global Bioenergies SA Chemicals: SpecialtyProcess Industries Develops industrial processes to convert renewable sources into hydrocarbons through fermentation | Process Industries |
MedinCell SA
 MedinCell SA Pharmaceuticals: MajorHealth Technology Provides therapeutic solutions | Health Technology |
Krono-Safe SA
 Krono-Safe SA Packaged SoftwareTechnology Services Provides software solutions for the development of embedded systems | Technology Services |
Tissium SA
 Tissium SA BiotechnologyHealth Technology Develops biomorphic and programmable polymers for tissue reconstruction | Health Technology |
Maat Pharma SA
 Maat Pharma SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops and commercializes patient-microbiome symbiosis to improve survival outcomes in oncology | Health Technology |
ForCity SAS
 ForCity SAS Miscellaneous Commercial ServicesCommercial Services Provides support services to the decision for the actors public and economic territories | Commercial Services |
Société Financière Aquitaine De Participation
Société Financière Aquitaine De Participation Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Oncodesign Precision Medicine SA
 Oncodesign Precision Medicine SA Pharmaceuticals: MajorHealth Technology Discovers and develops new molecules for the health treatments in oncology | Health Technology |
- Stock Market
- Insiders
- Karine Lignel
